Registro:

Referencias:

• Perkin, D.M., Pisani, P., Ferlay, J., Estimates of the worldwide incidence of 18 major cancers in 1985 (1993) Int. J. Cancer, 54, pp. 594-606
• Morris, M., Eifel, P.J., Lu, J., Grigsby, P.W., Levenback, C., Stevens, R.E., Rotman, M., Mutch, D.G., Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer (1999) N. Engl. J. Med., 340, pp. 1137-1143
• Keys, H.M., Bundy, B.N., Stehman, F.B., Muderspach, L.I., Chape, W.E., Suggs III, C.L., Walker, J.L., Gersell, D., Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma (1999) N. Engl. J. Med., 340, pp. 1154-1161
• Fletcher, G.H., Clinical dose-response curves of human malignant epithelial tumours (1973) Br. J. Radiol., 46, pp. 1-12
• Hreshchyshyn, M.M., Aron, B.S., Boronow, R.C., Franklin III, E.W., Shingleton, H.M., Blessing, J.A., Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis (1979) Int. J. Radiat. Oncol. Biol. Phys., 5, pp. 317-322
• Rose, P.G., Bundy, B.N., Watkins, E.B., Thigpen, J.T., Deppe, G., Maiman, M.A., Clarke-Person, D.L., Insalaco, S., Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer (1999) N. Engl. J. Med., 340, pp. 1144-1153
• Bergmark, K., Åvall-Lundqvist, E., Dickman, P.W., Henningsohn, L., Steineck, G., Vaginal changes and sexuality in women with a history of cervical cancer (1999) N. Engl. J. Med., 340, pp. 1383-1389
• Meijer, L., Borgne, A., Mulner, O., Chong, J.P.J., Blow, J.J., Inagaki, N., Inagaki, M., Moulinoux, J.-P., Biochemical and cellular effect of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5 (1997) Eur. J. Biochem., 243, pp. 527-536
• Schutte, B., Nieland, L., Van Engeland, M., Henfling, M.E.R., Meijer, L., Ramaekers, F.C.S., The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics (1997) Exp. Cell Res., 236, pp. 4-15
• Pippin, J.W., Qu, Q., Meijer, L., Shankland, S.J., Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist (1997) J. Clin. Invest., 100, pp. 2512-2520
• Meijer, L., Chemical inhibitors of cyclin-dependent kinases (1996) Trends Cell. Biol., 6, pp. 393-397
• Yakisich, J.S., Sidén, Å., Idoyaga Vargas, V., Eneroth, P., Cruz, M., Inhibition of DNA synthesis in human gliomas by roscovitine (1999) NeuroReport, 10, pp. 2563-2567
• Kim, Y.T., Cho, N.H., Park, S.W., Kim, J.W., Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma (1998) Gynecol. Oncol., 71, pp. 38-45
• Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T., Nakajima, T., Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions (1998) Am. J. Pathol., 153, pp. 1741-1748
• Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B., Galloway, D.A., Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein (1997) Oncogene, 11, pp. 2090-2100
• Jones, D.L., Alani, R.M., Munger, K., The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2 (1997) Genes Dev., 11, pp. 2101-2111
• Yakisich, J.S., Sidén, Å., Idoyaga Vargas, V., Eneroth, P., Cruz, M., Fast and sensitive method for simultaneous measurement of cell proliferation rate and drug sensitivity in rat cerebral cortex (1998) Exp. Neurol., 151, pp. 194-202
• Yakisich, J.S., Sidén, Å., Idoyaga Vargas, V., Eneroth, P., Cruz, M., Early inhibition of DNA synthesis in the developing rat cerebral cortex by the purine analogues olomoucine and roscovitine (1998) Biochem. Biophys. Res. Commun., 243, pp. 674-677
• Knockaert, M., Gray, N., Damiens, E., Chang, Y.T., Grellier, P., Grant, K., Fergusson, D., Meijer, L., Intracellular targets of cyclin-dependent kinase inhibitors: Identification by affinity chromatography using immobilised ligands (2000) Chem. Biol., 7, pp. 411-422
• Bosch, F.X., Manos, M.M., Munoz, N., Sherman, M., Jansen, A.M., Peto, J., Schiffman, M.H., Wheeler, C., Prevalence of human papillomavirus in cervical cancer: A worldwide perspective (1995) J. Natl. Cancer Inst., 87, pp. 796-802
• Zur Hausen, H., Papillomavirus infections - A major cause of human cancers (1996) Biochim. Biophys. Acta, 1288, pp. F55-F78
• Garbe, J., Wong, M., Wigington, D., Yaswen, P., Stampfer, M., Viral oncogenes accelerates conversion to immortality of cultured conditionally immortal human mammary epithelial cells (1999) Oncogene, 18, pp. 2169-2180
• Zehbe, I., Räatsch, A., Alunni-Fabronni, M., Burzlaf, A., Bakos, E., Durst, M., Wilander, E., Tommasino, M., Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: Evidence for an in vivo role in cervical lesions (1999) Oncogene, 18, pp. 2201-2211
• Duensing, S., Lee, L.Y., Basile, J., Piboonniyom, S., Gonzalez, S., Crum, C.P., Munger, K., The human papillomavirus type 16 E6 and E/ oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell cycle (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 10002-10007
• Duensing, S., Duensing, A., Crum, C.P., Munger, K., Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype (2001) Cancer Res., 61, pp. 2356-2360
• Schang, L.M., Rosemberg, A., Schaffer, P.A., Transcripcion of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases (1999) J. Virol., 73, pp. 2161-2172
• Schang, L.M., Phillips, J., Schaffer, P.A., Requirement for cellular cyclin-dependent kinase in herpes simplex virus replication and transcription (1999) J. Virol., 72, pp. 5626-5637
• Bresnahan, W.A., Boldogh, I., Chi, P., Thompson, E.A., Albrecht, T., Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication (1997) Virology, 231, pp. 239-247
• Wang, D., De la Fuente, C., Deng, L., Wang, L., Zilberman, I., Eadie, C., Healey, M., Kashanchi, F., Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors (2001) J. Virol., 75, pp. 7266-7279

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------